Mitesco, Inc. (MITI): Entry into a Material Definitive Agreement

Mitesco, Inc. (MITI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On October 5, 2026 Mitesco, Inc. (the “ Company”) received funding from a historical investor in the Company from a new 2026 Bridge Notes. The 10% Original Issue Discount Convertible Promissory Note (the “ 2026 Bridge Note”) w

Event · Offering · closed
Instrument
10% Original Issue Discount Convertible Promissory Note
Gross proceeds
$25,000
Coupon
10%
Price per share
$0.15
Maturity
12 months
Also in this documentExec change · resigned

Facts are quoted from the filing text and checked against it.

Original reporting
Published Oct 13, 2026, 10:01 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 10:05 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$MITI
Neutral
medium confidence
Mentioned
$MITI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MITINeutralLow
01

Why it matters

The financing introduces modest debt and dilution, which may slightly depress the share price, but the capital supports ongoing edge‑computing and AI projects.

02

Market read

Primary disclosure of a micro‑cap financing event with limited market impact.

03

What to watch

Potential strategic value of the investors behind the bridge note and the projects funded may not be reflected in the immediate dilution concerns.

Relevance 6/10Novelty 5/10Timing: same day filing

Background

Mitesco, Inc. filed an 8‑K reporting a bridge note financing, unregistered equity issuances, and a board resignation.

Company-level read

Ticker impact

$MITINeutralMedium confidence
Context

The company disclosed a new 2026 Bridge Note financing and unregistered equity issuances in its 8‑K filing.

Expected impact

likely slight downward pressure as market prices in dilution and new debt

Evidence & confidence

The bridge note adds $27,500 of debt and convertible shares at $0.15, while 2 × 500,000 restricted shares were issued, increasing share count.

Market effects

Minimal impact on the broader edge‑computing and AI hardware sector.

Limited to U.S. micro‑cap investors.

Low

Counterpoint

If the bridge note converts, the low conversion price could provide upside if the stock rallies above $0.15.

Key entities

  • ZSP Capital, LLC

    Provider of the 2026 Bridge Note.

  • Dr. Jordan Ballencic

    Resigned from the board.

Related articles

$SXTPHighAI 9/10

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On November 19, 2026, 60 Degrees Pharmaceuticals, Inc.…

60 DEGREES PHARMACEUTICALS, INC. (SXTP) filed an SEC Form 8-K — Other Events. Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On November 19, 2026, 60 Degrees Pharmaceuticals, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Na

$PHOSMed

First Phosphate secures UK interest in $220M financing – ICYMI

First Phosphate Corp. (PHOS) secured a letter of interest from UK Export Finance for $220M in financing, adding to existing sovereign support. The company aims to develop a Quebec phosphate mine, crucial for LFP battery supply chains. Management expects feasibility studies by Q1 2027 and a final investment decision by Q2 2028, with nearly $600M in sovereign financing anticipated.